Literature DB >> 15244362

The story of Clostridium botulinum: from food poisoning to Botox.

Patricia T Ting1, Anatoli Freiman.   

Abstract

In the last fifty years, Clostridium botulinum has become notorious for its ability to produce the deadly botulinum neurotoxins. While botulinum toxin A, better known as Botox, is universally recognised by the public as a cosmetic enhancement tool, the botulinum neurotoxins are commonly used off-label for many medical conditions in ophthalmology, neurology and dermatology. The versatility of these botulinum toxins has made Clostridium botulinum one of the most widely known bacterial pathogens in medical history. This article outlines the discovery of botulinum toxins through to their present day applications in medicine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15244362      PMCID: PMC4953590          DOI: 10.7861/clinmedicine.4-3-258

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  19 in total

1.  Botulinum Toxin in the Treatment of Pediatric Upper Limb Spasticity.

Authors:  Aloysia L Schwabe
Journal:  Semin Plast Surg       Date:  2016-02       Impact factor: 2.314

2.  Biosensor detection of botulinum toxoid A and staphylococcal enterotoxin B in food.

Authors:  Kim E Sapsford; Chris R Taitt; Nicole Loo; Frances S Ligler
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

3.  Botulinum neurotoxin types A, B, and E: fragmentations by autoproteolysis and other mechanisms including by O-phenanthroline-dithiothreitol, and association of the dinucleotides NAD(+)/NADH with the heavy chain of the three neurotoxins.

Authors:  Bibhuti R Dasgupta; Babu S Antharavally; William Tepp; Mary L Evenson
Journal:  Protein J       Date:  2005-08       Impact factor: 2.371

Review 4.  From poison to remedy: the chequered history of botulinum toxin.

Authors:  F J Erbguth
Journal:  J Neural Transm (Vienna)       Date:  2007-04-26       Impact factor: 3.575

5.  Synergistic effects of high hydrostatic pressure, mild heating, and amino acids on germination and inactivation of Clostridium sporogenes spores.

Authors:  Takateru Ishimori; Katsutoshi Takahashi; Masato Goto; Suguru Nakagawa; Yoshiaki Kasai; Yukifumi Konagaya; Hiroshi Batori; Atsushi Kobayashi; Hiroshi Urakami
Journal:  Appl Environ Microbiol       Date:  2012-09-14       Impact factor: 4.792

6.  Effect of Intragastric Botulinum Type A Injection Combined with a Low-Calorie High-Protein Diet in Adults with Overweight or Obesity.

Authors:  Po-Ke Hsu; Chia-Lin Wu; Yu-Hsuan Yang; James Cheng-Chung Wei
Journal:  J Clin Med       Date:  2022-06-10       Impact factor: 4.964

7.  Molecular composition and extinction coefficient of native botulinum neurotoxin complex produced by Clostridium botulinum hall A strain.

Authors:  Anne-Marie Bryant; Jenny Davis; Shuowei Cai; Bal Ram Singh
Journal:  Protein J       Date:  2013-02       Impact factor: 2.371

8.  Comparative immunochemical characteristics of botulinum neurotoxin type A and its associated proteins.

Authors:  Anne-Marie Bryant; Shuowei Cai; Bal Ram Singh
Journal:  Toxicon       Date:  2013-06-28       Impact factor: 3.033

9.  Dissecting interactions between nucleosides and germination receptors in Bacillus cereus 569 spores.

Authors:  Tetyana Dodatko; Monique Akoachere; Nadia Jimenez; Zadkiel Alvarez; Ernesto Abel-Santos
Journal:  Microbiology (Reading)       Date:  2009-12-24       Impact factor: 2.777

Review 10.  Phytoplankton Toxins and Their Potential Therapeutic Applications: A Journey toward the Quest for Potent Pharmaceuticals.

Authors:  Biswajita Pradhan; Jang-Seu Ki
Journal:  Mar Drugs       Date:  2022-04-18       Impact factor: 6.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.